Sofinnova Ventures is a leading venture capital firm based in San Francisco, CA, specializing in funding transformative biotech companies from inception to IPO. With a track record of funding over 110 companies, including 52 IPOs and 27 FDA-approved drugs, Sofinnova is a collaborative and experienced partner dedicated to advancing cures and improving lives through innovative biopharmaceuticals.
By deploying human and financial capital to turn dreams into drugs, Sofinnova binds science and innovation to support world-class entrepreneurs in challenging the status quo of medical care. With a focus on forging the path from drug development to company building, Sofinnova is committed to guiding entrepreneurs through every phase of growth, ultimately making a transformative impact on the field of life sciences.
Generated from the website